Raffaella Mondola

795 total citations
23 papers, 550 citations indexed

About

Raffaella Mondola is a scholar working on Pharmacology, Cellular and Molecular Neuroscience and Toxicology. According to data from OpenAlex, Raffaella Mondola has authored 23 papers receiving a total of 550 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Pharmacology, 8 papers in Cellular and Molecular Neuroscience and 7 papers in Toxicology. Recurrent topics in Raffaella Mondola's work include Neurotransmitter Receptor Influence on Behavior (7 papers), Forensic Toxicology and Drug Analysis (7 papers) and Cannabis and Cannabinoid Research (6 papers). Raffaella Mondola is often cited by papers focused on Neurotransmitter Receptor Influence on Behavior (7 papers), Forensic Toxicology and Drug Analysis (7 papers) and Cannabis and Cannabinoid Research (6 papers). Raffaella Mondola collaborates with scholars based in Italy and San Marino. Raffaella Mondola's co-authors include Maurizio Coppola, Giovanni Messina, Domenico Tafuri, Emanuela Viggiano, An. Viggiano, Marcellino Monda, Vincenzo De Luca, Rocco Luigi Picci, Giovanni Muscettola and Francesco Oliva and has published in prestigious journals such as SHILAP Revista de lepidopterología, Schizophrenia Research and Clinical Nutrition.

In The Last Decade

Raffaella Mondola

23 papers receiving 514 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Raffaella Mondola Italy 10 340 249 166 109 102 23 550
Maurizio Coppola Italy 9 345 1.0× 253 1.0× 167 1.0× 108 1.0× 101 1.0× 25 522
Chrystalla Kyriakou Italy 14 401 1.2× 226 0.9× 148 0.9× 78 0.7× 109 1.1× 16 606
Reynald Le Boisselier France 12 307 0.9× 147 0.6× 120 0.7× 228 2.1× 68 0.7× 39 565
Laura Hondebrink Netherlands 17 386 1.1× 285 1.1× 409 2.5× 88 0.8× 127 1.2× 33 738
Rebecca A. Jufer United States 14 302 0.9× 94 0.4× 227 1.4× 203 1.9× 127 1.2× 15 573
Dariusz Andrzejczak Poland 12 202 0.6× 116 0.5× 142 0.9× 63 0.6× 117 1.1× 22 457
Ernesto Solis United States 16 357 1.1× 173 0.7× 425 2.6× 98 0.9× 248 2.4× 24 852
Mario Ayestas United States 11 427 1.3× 289 1.2× 562 3.4× 150 1.4× 181 1.8× 15 837
Marta Más Spain 11 407 1.2× 344 1.4× 273 1.6× 251 2.3× 31 0.3× 23 723
E. Menoyo Spain 9 323 0.9× 243 1.0× 215 1.3× 237 2.2× 38 0.4× 14 590

Countries citing papers authored by Raffaella Mondola

Since Specialization
Citations

This map shows the geographic impact of Raffaella Mondola's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Raffaella Mondola with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Raffaella Mondola more than expected).

Fields of papers citing papers by Raffaella Mondola

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Raffaella Mondola. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Raffaella Mondola. The network helps show where Raffaella Mondola may publish in the future.

Co-authorship network of co-authors of Raffaella Mondola

This figure shows the co-authorship network connecting the top 25 collaborators of Raffaella Mondola. A scholar is included among the top collaborators of Raffaella Mondola based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Raffaella Mondola. Raffaella Mondola is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Coppola, Maurizio, et al.. (2022). Psilocybin for Treating Psychiatric Disorders: A Psychonaut Legend or a Promising Therapeutic Perspective?. SHILAP Revista de lepidopterología. 12(1). 41–52. 20 indexed citations
2.
Coppola, Maurizio, et al.. (2019). Craving for heroin: difference between methadone maintenance therapy patients with and without ADHD. Trends in Psychiatry and Psychotherapy. 41(1). 83–86. 5 indexed citations
3.
Coppola, Maurizio & Raffaella Mondola. (2018). Are physicians fully aware of the potential transgenerational and multigenerational effects of a large opioid misuse in the population?. Journal of Opioid Management. 14(4). 237–237. 1 indexed citations
4.
Oliva, Francesco, et al.. (2017). Blood homocysteine concentration and mood disorders with mixed features among patients with alcohol use disorder. BMC Psychiatry. 17(1). 181–181. 3 indexed citations
5.
Coppola, Maurizio & Raffaella Mondola. (2017). Correlation between plasma homocysteine levels and craving in alcohol dependent stabilized patients. Clinical Nutrition. 37(3). 1061–1065. 3 indexed citations
6.
Coppola, Maurizio & Raffaella Mondola. (2015). 4,4′‐DMAR: Chemistry, Pharmacology and Toxicology of a New Synthetic Stimulant of Abuse. Basic & Clinical Pharmacology & Toxicology. 117(1). 26–30. 6 indexed citations
7.
Coppola, Maurizio & Raffaella Mondola. (2014). Potential use of Magnolia officinalis bark polyphenols in the treatment of cannabis dependence. Medical Hypotheses. 83(6). 673–676. 6 indexed citations
8.
Coppola, Maurizio & Raffaella Mondola. (2014). Cannabis Consumption Systemic Adverse Effects. international journal high risk behaviors & addiction. 3(2). e18627–e18627. 4 indexed citations
9.
Coppola, Maurizio & Raffaella Mondola. (2014). Is there a role for palmitoylethanolamide in the treatment of depression?. Medical Hypotheses. 82(5). 507–511. 15 indexed citations
10.
Coppola, Maurizio & Raffaella Mondola. (2013). 5-Iodo-2-aminoindan (5-IAI): Chemistry, pharmacology, and toxicology of a research chemical producing MDMA-like effects. Toxicology Letters. 218(1). 24–29. 11 indexed citations
11.
Coppola, Maurizio & Raffaella Mondola. (2013). 4-methylamphetamine (4-MA): Chemistry, Pharmacology and Toxicology of a New Potential Recreational Drug. Mini-Reviews in Medicinal Chemistry. 13(14). 2097–2101. 2 indexed citations
12.
Coppola, Maurizio & Raffaella Mondola. (2013). Is methoxydine a new rapid acting antidepressant for the treatment of depression in alcoholics?. Medical Hypotheses. 81(1). 10–14. 3 indexed citations
13.
Coppola, Maurizio & Raffaella Mondola. (2013). Palmitoylethanolamide: From endogenous cannabimimetic substance to innovative medicine for the treatment of cannabis dependence. Medical Hypotheses. 81(4). 619–622. 8 indexed citations
14.
Coppola, Maurizio & Raffaella Mondola. (2012). Research chemicals marketed as legal highs: The case of pipradrol derivatives. Toxicology Letters. 212(1). 57–60. 12 indexed citations
15.
Coppola, Maurizio & Raffaella Mondola. (2012). Methoxetamine: From drug of abuse to rapid-acting antidepressant. Medical Hypotheses. 79(4). 504–507. 32 indexed citations
16.
Coppola, Maurizio & Raffaella Mondola. (2012). Synthetic cathinones: Chemistry, pharmacology and toxicology of a new class of designer drugs of abuse marketed as “bath salts” or “plant food”. Toxicology Letters. 211(2). 144–149. 192 indexed citations
17.
Coppola, Maurizio & Raffaella Mondola. (2011). 3,4-Methylenedioxypyrovalerone (MDPV): Chemistry, pharmacology and toxicology of a new designer drug of abuse marketed online. Toxicology Letters. 208(1). 12–15. 126 indexed citations
18.
Coppola, Maurizio & Raffaella Mondola. (2011). Potential action of betel alkaloids on positive and negative symptoms of schizophrenia: A review. Nordic Journal of Psychiatry. 66(2). 73–78. 33 indexed citations
19.
Monda, Marcellino, An. Viggiano, Raffaella Mondola, et al.. (2007). Olanzapine blocks the sympathetic and hyperthermic reactions due to cerebral injection of orexin A. Peptides. 29(1). 120–126. 40 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Maurizio Coppola Breakdown of academic impact, for papers by Chrystalla Kyriakou Breakdown of academic impact, for papers by Reynald Le Boisselier Breakdown of academic impact, for papers by Laura Hondebrink Breakdown of academic impact, for papers by Rebecca A. Jufer Breakdown of academic impact, for papers by Dariusz Andrzejczak Breakdown of academic impact, for papers by Ernesto Solis Breakdown of academic impact, for papers by Mario Ayestas Breakdown of academic impact, for papers by Marta Más Breakdown of academic impact, for papers by E. Menoyo
Rankless by CCL
2026